Taiwan FDA registration 43a298b5fb493ff90a10ba2ced5c08fd
BeneCheck Uric Acid Control Solution (Non-Sterile)
TW: 百捷尿酸品管液 (未滅菌)
Taiwan·Risk Class 1·MD·Qinli Biotechnology Co., Ltd. New North Plant·Registered Mar 07, 2022 – Mar 07, 2027ActiveRegistration details
- Analysis ID
- 43a298b5fb493ff90a10ba2ced5c08fd
- License Form
- Ministry of Health Medical Device Manufacturing No. 009487
Company information
- Manufacturer
- Qinli Biotechnology Co., Ltd. New North Plant
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- GENERAL LIFE BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Mar 07, 2022
- Expiry Date
- Mar 07, 2027
About this record
Access comprehensive regulatory information for BeneCheck Uric Acid Control Solution (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 43a298b5fb493ff90a10ba2ced5c08fd and manufactured by Qinli Biotechnology Co., Ltd. New North Plant. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices